Dynamk Capital is pleased to announce that FloDesign has closed a merger transaction with MilliporeSigma announced on October 10, 2019.
Burlington, Massachusetts, October 10, 2019 — MilliporeSigma today announced it has acquired FloDesign Sonics, of Wilbraham, Massachusetts, developer of a unique acoustic cell processing platform for the industrialization of cell and gene therapy manufacturing. Financial details were not disclosed.“Chimeric antigen receptor T cell therapies, or CAR-T for short, employs the body’s own immune systems to fight cancer by turning T cells into targeted therapeutics. This revolutionary cancer treatment is challenging and complex, with the process often taking up to a month,” said Udit Batra, CEO, MilliporeSigma. “Our acquisition of FloDesign Sonic will industrialize the manufacturing of autologous cell therapy, allowing these types of potentially life-saving treatments to reach more patients, faster.”
All trademarks are the property of their respective owners.